Search results
11 wrz 2024 · Since the announcement in April 2024 that it had agreed with the Department of Health and Human Services' (HHS) earlier recommendation to reschedule cannabis, the DEA opened a 60-day public comment...
- What rescheduling to Schedule III would mean for the cannabis industry
Given cannabis's status as a Schedule I drug, the...
- What rescheduling to Schedule III would mean for the cannabis industry
30 kwi 2024 · With the DEA set to reclassify marijuana as a less dangerous drug, weed companies will finally get a break from a punitive federal tax rate—and cannabis stocks have already rallied.
30 wrz 2024 · Cannabis, or marijuana, may be reclassified from a Schedule I to a Schedule III drug, loosening some federal restrictions. Here are five things to know.
29 maj 2024 · To put it simply, rescheduling keeps weed illegal at the federal level and descheduling does not. Schedule 3 drugs like ketamine are licensed and regulated by the FDA and DEA, among other...
20 maj 2024 · The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III.
12 wrz 2023 · Given cannabis's status as a Schedule I drug, the manufacture, sale, or possession of cannabis remains federally illegal, even for personal medical purposes.
28 lut 2024 · A 2021 study of the twelve biggest U.S. cannabis companies concluded that in 2020 they paid an aggregate total $272.28 million in excess taxes attributable solely to 280E. ... HHS’ historic recommendation that cannabis be rescheduled to Schedule III, if accepted by the DEA, will have far-reaching consequences that will permanently alter the ...